The economy is shifting, creating risks and opportunities for dividend investors. Check out stocks that align with my strategy and should reward patient investors.

Pfizer's strong Q4 2024 results showcase growth in cancer drugs and Vyndaqel sales. Learn why PFE stock is a top pick for ...

The January megadeals included transactions in the energy, financials, pharmaceuticals and materials sectors, signaling a ...

AbbVie's growth thrives on strong earnings, a robust immunology portfolio, and diversification. See why ABBV stock is a ...

GUSA comprises a portfolio of the largest 1,000 U.S. securities weighted by free-float market cap. Read why I've assigned GUSA ETF a neutral hold rating.

We recently published a list of 12 Best EV Stocks to Buy for The Long Term. In this article, we are going to take a look at ...

SentinelOne capitalizes on growth opportunities amidst market shifts like the CrowdStrike outage. Click here to read an ...

Deere's Q1 earnings still support a strong investment thesis. Explore future growth optimism & a 16% 6-year IRR base-case ...

Alibaba (BABA) surges 54% in a month driven by AI optimism & potential Apple partnership. Analysts largely bullish. Earnings ...

Alphabet is the cheapest Mag 7 stock, with a forward P/E ratio of only 18.2 for the fiscal year ending 2026. Click here to ...

REIT earnings shine with 61% beating estimates! Highlights include healthcare & retail strength, robust senior housing, and ...

Discover three underrated, high-dividend stocks positioned to capitalize on AI demand and market shifts. Explore more details ...